Progyny EV/EBIT PGNY
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2020.
- Today, Oct 23, 2026
- 18.0×
- 6-year median
- 66.3×
- Against its 6-year history
- 12th
- percentile: 0 is its lowest day, 100 its highest
- 6-year range
- 12.3× to 496×
- Peer median
- 15.1×
Progyny's EV/EBIT is 18.0× as of Oct 23, 2026.
That is below its 6-year median of 66.3×, lower than on 88% of days in the last 6 years.
Over that time it ranged from 12.3× in Apr 2026 to 496× in Mar 2021.
The median for 10 hospital and care facility stocks of a similar size is 15.1×.
EV/EBIT over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 18.0× | 12.3× | 23.9× |
| 2025 | 22.2× | 17.3× | 26.8× |
| 2024 | 18.6× | 14.6× | 69.5× |
| 2023 | 62.8× | 49.8× | 160× |
| 2022 | 139× | 95.8× | 228× |
| 2021 | 132× | 122× | 496× |
| 2020 | 428× | 304× | 428× |
Against its peers
Companies in Medical - Care Facilities nearest Progyny's size, closest first, today.
| Company | EV/EBIT |
|---|---|
| PGNYProgyny | 18.0× |
| ADUSAddus HomeCare | 15.1× |
| MDPediatrix Medical | 11.9× |
| HCSGHealthcare Services | 10.5× |
| ARDTArdent Health | 12.0× |
| PRVAPrivia Health | 250× |
| AVAHAveanna Healthcare | 14.6× |
| PNTGPennant | 25.1× |
| NHCNational Healthcare | 23.8× |
| USPHU S Physical Therapy | 19.8× |
| OMDAOmada Health | n/m |
| Peer median | 15.1× |
Where Progyny ranks
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on Progyny
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.